Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis

Table 1

Characteristics of studies included in the meta-analysis.

Study source	Follow-up (years)	Age at baseline (years)	No. of participants	Exposure assessment	ARB categories	CCB categories
Du et al., 2013 [8]	2	55-69	149	Questionnaire, 12-lead ECG, 24-hour Holter monitoring	Telmisartan	Nifedipine
Fogari et al., 2008 [11]	1	58-72	245	12-lead ECG, 24-hour Holter monitoring	Valsartan	Amlodipine
Fogari et al., 2006 [10]	1	56-71	222	12-lead ECG, 24-hour Holter monitoring	Losartan	Amlodipine
Fogari et al., 2012 [18]	1	60-75	378	12-lead ECG, 24-hour Holter monitoring	Telmisartan	Amlodipine
Yamabe et al., 2018 [19]	0.5	59-73	98	12-lead ECG, 24-hour Holter monitoring	Irbesartan	Amlodipine
Yamashita et al., 2011 [20]	1	57-75	318	12-lead ECG, 24-hour Holter monitoring	Candesartan	Amlodipine
Zhao et al., 2018 [17]	1	56-74	85	12-lead ECG, 24-hour Holter monitoring	Valsartan	Amlodipine